- Home
- CLDI vs NAII Comparison
CLDI vs NAII Comparison
Compare CLDI & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- NAII
- Stock Information
- Founded
- CLDI 2014
- NAII 1980
- Country
- CLDI United States
- NAII United States
- Employees
- CLDI N/A
- NAII N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- NAII Medicinal Chemicals and Botanical Products
- Sector
- CLDI Health Care
- NAII Health Care
- Exchange
- CLDI Nasdaq
- NAII Nasdaq
- Market Cap
- CLDI 15.7M
- NAII 18.6M
- IPO Year
- CLDI N/A
- NAII 1987
- Fundamental
- Price
- CLDI $0.40
- NAII $3.27
- Analyst Decision
- CLDI Strong Buy
- NAII
- Analyst Count
- CLDI 2
- NAII 0
- Target Price
- CLDI $15.00
- NAII N/A
- AVG Volume (30 Days)
- CLDI 202.0K
- NAII 21.8K
- Earning Date
- CLDI 05-20-2025
- NAII 05-20-2025
- Dividend Yield
- CLDI N/A
- NAII N/A
- EPS Growth
- CLDI N/A
- NAII N/A
- EPS
- CLDI N/A
- NAII N/A
- Revenue
- CLDI N/A
- NAII $121,853,000.00
- Revenue This Year
- CLDI N/A
- NAII N/A
- Revenue Next Year
- CLDI N/A
- NAII N/A
- P/E Ratio
- CLDI N/A
- NAII N/A
- Revenue Growth
- CLDI N/A
- NAII N/A
- 52 Week Low
- CLDI $0.35
- NAII $2.57
- 52 Week High
- CLDI $4.90
- NAII $7.26
- Technical
- Relative Strength Index (RSI)
- CLDI 36.62
- NAII 57.22
- Support Level
- CLDI $0.40
- NAII $3.21
- Resistance Level
- CLDI $0.46
- NAII $3.34
- Average True Range (ATR)
- CLDI 0.04
- NAII 0.24
- MACD
- CLDI 0.00
- NAII 0.07
- Stochastic Oscillator
- CLDI 9.73
- NAII 79.33
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.